Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy

Diabetes

Volumn 46, Issue 11, 1997, Pages 1875-1880

  Yokoyama, Hiroki ^a   Høyer, Poul E ^b   Hansen, Pernille M ^a   Van Den Born, Jacob ^c   Jensen, Tonny ^a   Berden, Jo H M ^c   Deckert, Torsten ^a   Garbarsch, Charly ^b  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COLLAGEN TYPE 4; CREATININE; PROTEOHEPARAN SULFATE;

ADULT; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROSPECTROPHOTOMETRY; MUSCLE BIOPSY; PRIORITY JOURNAL; PROTEINURIA; SKELETAL MUSCLE;

EID: 0030662123     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.11.1875     Document Type: Article

References (30)

1. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Stereo hypothesis. Diabetologia 32:219-226, 1989
2. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type I (insulin-dependent) diabetes mellitus. Diabetologia 28:590-597, 1985
3. Borch-Johnsen K, Kreiner S: Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 312:1651-1654, 1987
4. Sandeman DD, Shore AC, Tooke JE: Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 327:760-764, 1992
5. Bent-Hansen L, Feldt-Rasmussen B, Kverneland A, Deckert T: Plasma disappearance of glycated and non-glycated albumin in Type 1 (insulin-dependent) diabetes mellitus: evidence for charge dependent alterations of the plasma to lymph pathway. Diabetologia 36:361-363, 1993
6. Lindahl U, Kusche M, Lidholt K, Oscarsson L-G: Biosynthesis of heparin and heparan sulfate. In Heparin and Related Polysaccharides. Structure and Activities. Ofosu FA, Danishetsky I, Hirsh J, Eds. Ann N Y Acad Sci 556:36-50, 1989
7. Nerlich A, Schleicher E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 1:39:889-899, 1991
8. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM: Heparan sulfate proteoglycan in the glomerular basement membrane in type I diabetes mellitus. Kidney Int 41:1070-1080, 1992
9. Makino H, Ikeda S, Haramoto T, Ota Z: Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy. Nephron 61:415-421, 1992
10. Van den Born J, van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Weening JJ, Berden JHM: Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int 43:454-463, 1993
11. Parthasarathy N, Spiro RG: Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31:738-741, 1982
12. Tamsma JT, van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, Wieslander J, Schrama E, Hermans J, Veerkamp JH: Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulfate in the glomerular basement membrane. Diabetologia 37:313-320, 1994
13. Van den Born J, van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Berden JHM: A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41:115-123, 1992
14. Feldt-Rasmussen B: Increased transcapillary escape rate of albumin in type I (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29:282-286, 1986
15. Nørgaard K, Jensen T, Feldt-Rasmussen B: Transcapillary escape rate of albumin in hypertensive patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 36:57-61, 1993
16. Van den Born J, van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM: Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. J Histochem Cytochem 42:89-102, 1994
17. Feldt-Rasmussen B, Dinesen B, Deckert M: Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539-544, 1985
18. Østerby R: Glomerular structural changes in type I (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35:803-812, 1992
19. Van den Born J, Gunnarsson K, Bakker MAH, Kjellén L, Kusche-Gullberg M, Maccarana M, Berden JHM, Lindahl U: Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 270:31303-31309, 1995
20. Kjellén L, Bielefeld D, Hook M: Reduced sulfaation of liver heparan sulfate in experimental diabetic rats. Diabetes 32:337-342, 1983
21. Kofoed-Enevoldsen A, Noonan D, Deckert T: Diabetes mellitus induced inhibition of glucosaminyl N-deacetylase: effect of short-term blood glucose in diabetic rats. Diabetologia 36:310-315, 1993
22. Kofoed-Enevoldsen A, Kotinis A, Deckert T: Poor metabolic control decreases N-deacetylase activity in type 1 diabetic patients. Diabetologia 37 (Suppl. 1):A3, 1994
23. Van den Born J, Berden JHM; Is microalbuminuria in diabetes due to changes in glomerular heparan sulfate? Nephrol Dial Transplant 10:1277-1296, 1995
24. Kallunki P, Tryggvason K: Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Cell Biol 116:559-571, 1992
25. Yamamoto T, Nakamura T, Noble NA, Ruoslahti W, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 90:1814-1818, 1993
26. Templeton DM: Retention of glomerular basement membrane proteoglycans accompanying loss of anionic site staining in experimental diabetes. Lab Invest 61:202-211, 1989
27. Zhu D, Kim Y, Steffes MW, Groppoli TJ, Butkowski RJ, Mauer SM: Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. Kidney Int 45:425-433, 1994
28. Falk RJ, Scheinman JI, Mauer SM, Michael AF: Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32 (Suppl. 2):34-39, 1983
29. Kim Y, Kleppel MM, Butkowski R, Mauer SM, Wieslander J, Michael AF: Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138:413-420, 1991
30. Vyas SV, Burne MJ, Pratt L, Comper WD: Glomerular processing of dextran sulfate during transcapillary transport. Arch Biochem Biaphys 332:205-212, 1996